Department of Pharmaceutics & Analytical Chemistry, Faculty of Pharmaceutical Science, University of Copenhagen, Denmark.
Drug Dev Ind Pharm. 2013 May;39(5):799-806. doi: 10.3109/03639045.2012.710634. Epub 2012 Aug 8.
There is an increasing interest on self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of poorly water-soluble drugs. However, development of SNEDDS is often driven by empiric, pseudo-ternary diagrams and solubility of drugs, and it is lacking a systematic approach for evaluating impact of excipients on the performance of formulations as well as the fate of drug. The aim of this study was to rationalize the SNEDDS development procedure and to get a better understanding on the role of excipients on the SNEDDS. The formulations consist of soybean oil or rapeseed oil, Cremophor(®) RH40, Maisine™ 35-1 and ethanol. Response surface methodology (RSM) was used in the development of SNEDDS. Significant advantages of RSM were found in reducing the work load and determining the impact of excipients on formulation characteristics. The most significant factor in influencing droplet size was the co-surfactant Maisine™ 35-1, the droplet size increased with increasing concentration of Maisine™ 35-1. It suggests that Maisine™ 35-1 has double functions in the SNEDDS; it functions as co-surfactant to improve the emulsification of oil, meanwhile it also works as the oil phase and results in larger droplets. A significant reduction in droplet size was interestingly observed when fenofibrate was loaded in the vehicles, probably due to the surface activity of fenofibrate, promoting the self-emulsifying process. It was evident that drug precipitation during lipolysis was not affected by the level of co-solvent ethanol in the formulation, while it had pronounced impact on drug solubilization during the initial dispersion stage.
人们对自微乳药物传递系统(SNEDDS)越来越感兴趣,希望将其用于口服传递难溶性药物。然而,SNEDDS 的开发通常是基于经验、伪三元相图和药物溶解度,缺乏系统的方法来评估赋形剂对制剂性能和药物命运的影响。本研究旨在合理化 SNEDDS 的开发程序,并更好地了解赋形剂在 SNEDDS 中的作用。这些制剂由大豆油或菜籽油、Cremophor(®)RH40、Maisine™35-1 和乙醇组成。响应面法(RSM)用于开发 SNEDDS。在减少工作量和确定赋形剂对制剂特性的影响方面,RSM 具有显著优势。影响粒径的最显著因素是辅助乳化剂 Maisine™35-1,随着 Maisine™35-1 浓度的增加,粒径增大。这表明 Maisine™35-1 在 SNEDDS 中具有双重功能;它既可以作为辅助乳化剂来改善油的乳化,同时也可以作为油相,导致粒径增大。令人感兴趣的是,当将非诺贝特载入载体中时,粒径显著减小,这可能是由于非诺贝特的表面活性,促进了自乳化过程。显然,在脂肪酶解过程中药物沉淀不受制剂中助溶剂乙醇水平的影响,而在初始分散阶段,药物溶解度则受其显著影响。